THE SHORT ANSWER

For a strategic PT sale, compare supported continuing earnings and actual buyer terms rather than assuming a platform multiple. Price the necessary clinical and administrative work after the owner leaves, reconcile actual payer collections, and separate documented operations from proposed growth. A headline offer, commercial-payer target, completion rate or low owner-hours figure does not establish value or proceeds.

Support managed earnings after necessary work

Reconcile completed services, billing reductions, denials, refunds, actual receipts and full-year accounts on consistent definitions. Include clinical/support payroll, supervision, premises, equipment, billing/provider costs and shared overhead. Document each proposed adjustment using the earnings bridge; a personal, owner-pay or renovation label alone does not remove a necessary cost.

Hypothetical arithmetic only: $200,000 − $80,000 − $30,000 = $90,000; specified roles total $110,000. Starting remainder explicitly excludes both roles; do not deduct work already included. Other omitted costs/work, investment, financing and tax excluded. Not a compensation benchmark, complete adjusted EBITDA, valuation or client result.
Invented omitted-role earnings bridgeAssumption/result
Assumed operating remainder before two omitted roles$200,000
Distinct necessary continuing clinician role−$80,000
Distinct necessary continuing administration role−$30,000
Remainder after those stated roles$90,000

Verify the actual work, available appropriately credentialed people, compensation/benefits and capacity using the coverage worksheet. Reducing owner clinical hours without supported replacement work does not independently increase managed earnings.

Use actual payer realization and referral evidence

Reconcile actual payer/service cohorts through allowed amounts, denials, collection timing, recoupment questions and net cash rather than ranking payers by label. Include billing effort and other relevant costs. Do not assume an ideal commercial/Medicaid percentage, a guaranteed negotiation outcome or a fixed payer-mix premium.

Describe referral history and completed-service collections using permitted aggregate evidence and explicit periods. Have healthcare counsel review actual referral and ownership arrangements. Patient choice, clinical appropriateness and service outcomes need separate professional assessment; completion, return, satisfaction or review-count thresholds do not establish quality or a sale premium. Proposed new services, sites or employer relationships require their own cost, permission and demand assumptions.

Identify what the market evidence can support

BizBuySell’s broad medical category combines physical therapy with many other specialties.

(BizBuySell: broad medical-practice sold benchmarks)

Use the clinic financial guide for the historical sample and its limits. It is not a PT platform EBITDA benchmark. Obtain relevant closed evidence matching scale, services, payer/collection definition, clinician work, location and asset scope; mark unknown fields rather than assigning a universal strategic-buyer range.

CMS describes Medicare enrollment and maintaining current information.

(CMS: Medicare provider and supplier enrollment overview)

Resolve actual proposed entity, clinicians, location, services, payer/enrollment and ownership conditions with appropriate advisors/authorities. Use the consent register for premises, payer/vendor and actual people arrangements; assess actual equipment/software and investment needs.

Compare cash, transition, contingent and rollover terms

Request a clear proposal showing cash at closing, later payments, contingent conditions, any rollover interest, required employment/clinical work, control rights and continuing obligations. Have transaction, tax and healthcare advisors review actual terms and compare stated downside/collection/transition scenarios. A headline amount is separate from supported cash proceeds or realizable rollover value.

Define receivables, claims/overpayment questions, deposits, prepaid services, refunds and patient duties using the delivery guide. HHS describes conditions on health-data use/disclosure and safeguards.

(HHS: health-information privacy and security overview)

Have privacy counsel determine permitted evidence, custody/access and migration; begin with approved aggregates rather than identifiable uploads based on an NDA alone. No strategic premium, forced payer change, mandatory service expansion or completed-sale outcome is assumed.

Owner questions

Does a strategic buyer guarantee a higher PT multiple?

Compare supported continuing earnings, relevant closed evidence and actual cash/contingent/rollover terms.

Should I remove all owner clinical pay before showing EBITDA?

Identify necessary continuing work, confirm whether its costs are already included, and support any replacement-cost adjustment.

Does an ideal payer mix prove a price premium?

Assess actual net realization, collection timing, costs and proposed rights; no universal percentage target establishes value.

Put this decision into numbers.

Use explicit assumptions and keep the result as a starting point for your advisors.

Seller proceeds planner ↗

Discuss your sale goals confidentially →

Sources and review scope

Source review completed . The sources below support the identified concepts or rules; they do not validate hypothetical amounts or a valuation of your business.

Confirm tax, legal, accounting and lending applications with the relevant professionals. Historical market observations describe the stated period and reported sample.

Using this guide

This is educational material. Industry figures and program rules can change; check the original sources and your advisors before applying them to a transaction. Calculator scenarios are not appraisals, lending decisions, or offers.

Our content and calculator methodology →

Continue your research

Sell a Physical Therapy Clinic: Prepare Collections, Clinicians and Payer Conditions →Physical Therapy Clinic Valuation: Supported Collections and Continuing Work →SDE vs. EBITDA vs. TTM: How Sellers Should Present Earnings →